Global Vaccines Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Vaccines Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and remember it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
According to APO Research, The global Vaccines market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Vaccines include GSK, Sanofi, Merck, Pfizer, Novartis(GSK), CSL, MedImmune LLC, J&J(Crucell) and China National Biotec, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccines.
The Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan
Vaccines segment by Type

Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others
Vaccines segment by Application

Rabies vaccine
Influenza vaccine
HPV vaccine
Hepatitis B
Hepatitis A
Leprosy vaccine
Polio vaccine
JE vaccine
Others
Vaccines Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Vaccines Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Vaccines Sales Estimates and Forecasts (2019-2030)
1.3 Vaccines Market by Type
1.3.1 Recombinant Vaccines
1.3.2 Viral Vaccines
1.3.3 Polysaccharide Vaccines
1.3.4 Others
1.4 Global Vaccines Market Size by Type
1.4.1 Global Vaccines Market Size Overview by Type (2019-2030)
1.4.2 Global Vaccines Historic Market Size Review by Type (2019-2024)
1.4.3 Global Vaccines Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Vaccines Sales Breakdown by Type (2019-2024)
1.5.2 Europe Vaccines Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Vaccines Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Vaccines Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Vaccines Sales Breakdown by Type (2019-2024)
2 Global Market Dynamics
2.1 Vaccines Industry Trends
2.2 Vaccines Industry Drivers
2.3 Vaccines Industry Opportunities and Challenges
2.4 Vaccines Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Vaccines Revenue (2019-2024)
3.2 Global Top Players by Vaccines Sales (2019-2024)
3.3 Global Top Players by Vaccines Price (2019-2024)
3.4 Global Vaccines Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Vaccines Key Company Manufacturing Sites & Headquarters
3.6 Global Vaccines Company, Product Type & Application
3.7 Global Vaccines Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Vaccines Market CR5 and HHI
3.8.2 Global Top 5 and 10 Vaccines Players Market Share by Revenue in 2023
3.8.3 2023 Vaccines Tier 1, Tier 2, and Tier 3
4 Vaccines Regional Status and Outlook
4.1 Global Vaccines Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Vaccines Historic Market Size by Region
4.2.1 Global Vaccines Sales in Volume by Region (2019-2024)
4.2.2 Global Vaccines Sales in Value by Region (2019-2024)
4.2.3 Global Vaccines Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Vaccines Forecasted Market Size by Region
4.3.1 Global Vaccines Sales in Volume by Region (2025-2030)
4.3.2 Global Vaccines Sales in Value by Region (2025-2030)
4.3.3 Global Vaccines Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 Vaccines by Application
5.1 Vaccines Market by Application
5.1.1 Rabies vaccine
5.1.2 Influenza vaccine
5.1.3 HPV vaccine
5.1.4 Hepatitis B
5.1.5 Hepatitis A
5.1.6 Leprosy vaccine
5.1.7 Polio vaccine
5.1.8 JE vaccine
5.1.9 Others
5.2 Global Vaccines Market Size by Application
5.2.1 Global Vaccines Market Size Overview by Application (2019-2030)
5.2.2 Global Vaccines Historic Market Size Review by Application (2019-2024)
5.2.3 Global Vaccines Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Vaccines Sales Breakdown by Application (2019-2024)
5.3.2 Europe Vaccines Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Vaccines Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Vaccines Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Vaccines Sales Breakdown by Application (2019-2024)
6 Company Profiles
6.1 GSK
6.1.1 GSK Comapny Information
6.1.2 GSK Business Overview
6.1.3 GSK Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Vaccines Product Portfolio
6.1.5 GSK Recent Developments
6.2 Sanofi
6.2.1 Sanofi Comapny Information
6.2.2 Sanofi Business Overview
6.2.3 Sanofi Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Vaccines Product Portfolio
6.2.5 Sanofi Recent Developments
6.3 Merck
6.3.1 Merck Comapny Information
6.3.2 Merck Business Overview
6.3.3 Merck Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Vaccines Product Portfolio
6.3.5 Merck Recent Developments
6.4 Pfizer
6.4.1 Pfizer Comapny Information
6.4.2 Pfizer Business Overview
6.4.3 Pfizer Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Vaccines Product Portfolio
6.4.5 Pfizer Recent Developments
6.5 Novartis(GSK)
6.5.1 Novartis(GSK) Comapny Information
6.5.2 Novartis(GSK) Business Overview
6.5.3 Novartis(GSK) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novartis(GSK) Vaccines Product Portfolio
6.5.5 Novartis(GSK) Recent Developments
6.6 CSL
6.6.1 CSL Comapny Information
6.6.2 CSL Business Overview
6.6.3 CSL Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 CSL Vaccines Product Portfolio
6.6.5 CSL Recent Developments
6.7 MedImmune LLC
6.7.1 MedImmune LLC Comapny Information
6.7.2 MedImmune LLC Business Overview
6.7.3 MedImmune LLC Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.7.4 MedImmune LLC Vaccines Product Portfolio
6.7.5 MedImmune LLC Recent Developments
6.8 J&J(Crucell)
6.8.1 J&J(Crucell) Comapny Information
6.8.2 J&J(Crucell) Business Overview
6.8.3 J&J(Crucell) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 J&J(Crucell) Vaccines Product Portfolio
6.8.5 J&J(Crucell) Recent Developments
6.9 China National Biotec
6.9.1 China National Biotec Comapny Information
6.9.2 China National Biotec Business Overview
6.9.3 China National Biotec Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 China National Biotec Vaccines Product Portfolio
6.9.5 China National Biotec Recent Developments
6.10 Tiantan
6.10.1 Tiantan Comapny Information
6.10.2 Tiantan Business Overview
6.10.3 Tiantan Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Tiantan Vaccines Product Portfolio
6.10.5 Tiantan Recent Developments
6.11 Hualan
6.11.1 Hualan Comapny Information
6.11.2 Hualan Business Overview
6.11.3 Hualan Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hualan Vaccines Product Portfolio
6.11.5 Hualan Recent Developments
6.12 Kangtai
6.12.1 Kangtai Comapny Information
6.12.2 Kangtai Business Overview
6.12.3 Kangtai Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Kangtai Vaccines Product Portfolio
6.12.5 Kangtai Recent Developments
6.13 Hissen
6.13.1 Hissen Comapny Information
6.13.2 Hissen Business Overview
6.13.3 Hissen Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hissen Vaccines Product Portfolio
6.13.5 Hissen Recent Developments
6.14 Jintan
6.14.1 Jintan Comapny Information
6.14.2 Jintan Business Overview
6.14.3 Jintan Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Jintan Vaccines Product Portfolio
6.14.5 Jintan Recent Developments
7 North America by Country
7.1 North America Vaccines Sales by Country
7.1.1 North America Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Vaccines Sales by Country (2019-2024)
7.1.3 North America Vaccines Sales Forecast by Country (2025-2030)
7.2 North America Vaccines Market Size by Country
7.2.1 North America Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Vaccines Market Size by Country (2019-2024)
7.2.3 North America Vaccines Market Size Forecast by Country (2025-2030)
8 Europe by Country
8.1 Europe Vaccines Sales by Country
8.1.1 Europe Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Vaccines Sales by Country (2019-2024)
8.1.3 Europe Vaccines Sales Forecast by Country (2025-2030)
8.2 Europe Vaccines Market Size by Country
8.2.1 Europe Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Vaccines Market Size by Country (2019-2024)
8.2.3 Europe Vaccines Market Size Forecast by Country (2025-2030)
9 Asia-Pacific by Country
9.1 Asia-Pacific Vaccines Sales by Country
9.1.1 Asia-Pacific Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Vaccines Sales by Country (2019-2024)
9.1.3 Asia-Pacific Vaccines Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Vaccines Market Size by Country
9.2.1 Asia-Pacific Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Vaccines Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Vaccines Market Size Forecast by Country (2025-2030)
10 Latin America by Country
10.1 Latin America Vaccines Sales by Country
10.1.1 Latin America Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Vaccines Sales by Country (2019-2024)
10.1.3 Latin America Vaccines Sales Forecast by Country (2025-2030)
10.2 Latin America Vaccines Market Size by Country
10.2.1 Latin America Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Vaccines Market Size by Country (2019-2024)
10.2.3 Latin America Vaccines Market Size Forecast by Country (2025-2030)
11 Middle East and Africa by Country
11.1 Middle East and Africa Vaccines Sales by Country
11.1.1 Middle East and Africa Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Vaccines Sales by Country (2019-2024)
11.1.3 Middle East and Africa Vaccines Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Vaccines Market Size by Country
11.2.1 Middle East and Africa Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Vaccines Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Vaccines Market Size Forecast by Country (2025-2030)
12 Value Chain and Sales Channels Analysis
12.1 Vaccines Value Chain Analysis
12.1.1 Vaccines Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Vaccines Production Mode & Process
12.2 Vaccines Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Vaccines Distributors
12.2.3 Vaccines Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings